Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01922245 · ClinicalTrials.gov registry record · NA
tDCS and Aphasia Treatment
A NA study, sponsored by Hunter College of City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01922245 is a NA study that has completed, run by Hunter College of City University of New York. The registered enrollment target is 1 participants.
The verdict
NCT01922245, a NA study, has completed, sponsored by Hunter College of City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This project will investigate the use of noninvasive brain stimulation in the form of tDCS (transcranial direct current stimulation) in conjunction with speech-language therapy, for the improvement of language production in stroke survivors with aphasia. The hypothesis is that anodal tDCS and speech-language therapy will facilitate improved outcomes compared to speech therapy alone.
Interventions
- DEVICE Soterix 1x1 tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01922245
The ClinicalTrials.gov registry entry for NCT01922245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hunter College of City University of New York, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Soterix 1x1 tDCS is the first listed.
NCT01922245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01922245 about?
NCT01922245 is a clinical study titled "tDCS and Aphasia Treatment". This project will investigate the use of noninvasive brain stimulation in the form of tDCS (transcranial direct current stimulation) in conjunction with speech-language therapy, for the improvement of language production in stroke survivors with aphasia. The hypothesis is that anodal tDCS and speech...
What is the current status of trial NCT01922245?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2013-07. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01922245?
The interventions under investigation include: Soterix 1x1 tDCS (DEVICE).
Who is sponsoring clinical trial NCT01922245?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.